Sridevi Rajeeve, MD - Guest Faculty

Assistant Attending L1, Myeloma & Cellular Therapy Services Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
New York
NY
Specialties
Myeloma & Cellular Therapy

Dr. Sridevi Rajeeve is a hematologist-oncologist and physician-researcher specializing in plasma cell disorders and cellular therapies. Along with colleagues at Memorial Sloan-Kettering Cancer Center (MSK). Dr. Rajeeve offers a range of treatment options, including standard-of-care medications and cutting-edge clinical trials.

"A cancer diagnosis abruptly transforms the lives of both patients and their loved ones. Each patient, their support systems, and environment are unique; my goal is to holistically think about all of these elements and, together with my patients, decide what treatment approach is best, based on their individual needs, wishes, and goals. I value communication and place high importance on patients and their caregivers understanding the disease process, treatment options, benefits, risks, and alternatives." Dr. Rajeeve. 

 

Conflict of Interest

None

 

This event was moderated by Dr. Sridevi Rajeeve, Memorial Sloan Kettering, joined by speakers: Dr. Hamza Hashmi, Memorial Sloan Kettering, Dr. Michele Stanchina, University of Miami, Dr. Muhammad Salman Faisal, Oklahoma University, and Dr. Andrew Srisuwananukorn, Ohio State University

Topics include:

- Myeloma 101: Facts and Fiction of the 'Myeloma Marathon'

- Updates in DLBCL

- Treatment Basics of Bone Marrow Transplant

- Frontline Therapies in Myelofibrosis

- Panel Discussions and a Question-and-Answer session